Moreover, the MYC-driven secretion of exosomes containing miR-105 in breast cancer cells triggers a MYC-gene expression program in surrounding CAFs, leading to metabolic reprogramming that enhances glucose and glutamine metabolism to fuel adjacent cancer cells. Here, MYC is linked to breast cancer.